Literature DB >> 19800232

Gait analysis using accelerometry in dystrophin-deficient dogs.

Inès Barthélémy1, Eric Barrey, Jean-Laurent Thibaud, Ane Uriarte, Thomas Voit, Stéphane Blot, Jean-Yves Hogrel.   

Abstract

Dogs affected with Golden Retriever Muscular Dystrophy (GRMD) exhibit striking clinical similarities with patients suffering from Duchenne muscular dystrophy (DMD), particularly gait impairments. The purpose of this study was to describe the use and reliability of accelerometry in gait assessment of dogs with muscular dystrophy. Eight healthy and 11 GRMD adult dogs underwent three gait assessment sessions, using accelerometry. Three-axial recordings of accelerations were performed, and gait variables calculated. Total power, force and regularity of accelerations, stride length and speed, normalized by height at withers, stride frequency, and cranio-caudal power were significantly decreased, whereas medio-lateral power was significantly increased in GRMD dogs. Moreover, these variables were repeatable within and between sessions. Accelerometry provides reliable variables which highlight specific gait patterns of GRMD dogs, describing objectively and quantitatively their slow, short-stepped, and swaying gait. As it is easy to set-up, quick to perform and inexpensive, accelerometry represents a useful tool, to assess locomotion during pre-clinical trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800232     DOI: 10.1016/j.nmd.2009.07.014

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  20 in total

Review 1.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

2.  Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.

Authors:  Karl Rouger; Thibaut Larcher; Laurence Dubreil; Jack-Yves Deschamps; Caroline Le Guiner; Gregory Jouvion; Bruno Delorme; Blandine Lieubeau; Marine Carlus; Benoît Fornasari; Marine Theret; Priscilla Orlando; Mireille Ledevin; Céline Zuber; Isabelle Leroux; Stéphane Deleau; Lydie Guigand; Isabelle Testault; Elisabeth Le Rumeur; Marc Fiszman; Yan Chérel
Journal:  Am J Pathol       Date:  2011-09-13       Impact factor: 4.307

Review 3.  The paradox of muscle hypertrophy in muscular dystrophy.

Authors:  Joe N Kornegay; Martin K Childers; Daniel J Bogan; Janet R Bogan; Peter Nghiem; Jiahui Wang; Zheng Fan; James F Howard; Scott J Schatzberg; Jennifer L Dow; Robert W Grange; Martin A Styner; Eric P Hoffman; Kathryn R Wagner
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-02       Impact factor: 1.784

4.  A Wearable Magnet-Based System to Assess Activity and Joint Flexion in Humans and Large Animals.

Authors:  Feini Qu; Brendan D Stoeckl; Peter M Gebhard; Todd J Hullfish; Josh R Baxter; Robert L Mauck
Journal:  Ann Biomed Eng       Date:  2018-08-06       Impact factor: 3.934

5.  Gait characteristics in a canine model of X-linked myotubular myopathy.

Authors:  Melissa A Goddard; Emily Burlingame; Alan H Beggs; Anna Buj-Bello; Martin K Childers; Anthony P Marsh; Valerie E Kelly
Journal:  J Neurol Sci       Date:  2014-08-29       Impact factor: 3.181

6.  Quantitative phenotyping of Duchenne muscular dystrophy dogs by comprehensive gait analysis and overnight activity monitoring.

Authors:  Jin-Hong Shin; Brian Greer; Chady H Hakim; Zhongna Zhou; Yu-chia Chung; Ye Duan; Zhihai He; Dongsheng Duan
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

7.  Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs.

Authors:  Inès Barthélémy; Eric Barrey; Pablo Aguilar; Ane Uriarte; Matthias Le Chevoir; Jean-Laurent Thibaud; Thomas Voit; Stéphane Blot; Jean-Yves Hogrel
Journal:  BMC Musculoskelet Disord       Date:  2011-04-13       Impact factor: 2.362

8.  Motor physical therapy affects muscle collagen type I and decreases gait speed in dystrophin-deficient dogs.

Authors:  Thaís P Gaiad; Karla P C Araujo; Júlio C Serrão; Maria A Miglino; Carlos Eduardo Ambrósio
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

9.  Identification of behaviour in freely moving dogs (Canis familiaris) using inertial sensors.

Authors:  Linda Gerencsér; Gábor Vásárhelyi; Máté Nagy; Tamas Vicsek; Adam Miklósi
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

10.  Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.

Authors:  Inès Barthélémy; Ane Uriarte; Carole Drougard; Yves Unterfinger; Jean-Laurent Thibaud; Stéphane Blot
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.